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SUMMARY
Because European maximum guidance values of mycotoxins are only available for feed,
mycotoxin exposure in animals is mainly monitored by feed analysis. However, proper sample
collection is needed to ensure reliable results because of uneven distributions and disproportional
spread ofmycotoxins in feedwhich can hamper the evaluation ofmycotoxin exposure in animals.
A cross-sectional studywas performed on 40 randomly selected broiler farms in Belgium. During
a farm visit at the animal’s age of 28 d, a pooled feed sample at the beginning and the end of the
feed line was collected. Feed samples were analyzed by a validated multimycotoxin LC-MS/MS
method. Moreover, serum samples were collected from 10 randomly selected chickens per farm.
Serum concentrations of mycotoxins and major in vivo phase I metabolites were analyzed
quantitatively, whereas the presence of phase II metabolites was determined in a qualitative
approach by an UPLC-HRMS method. Deoxynivalenol (DON) was the most frequently occur-
ring mycotoxin, being present in 74% of the feed samples, with an average concentration of
270 6 171 mg/kg and a maximum concentration of 751 mg/kg in positive samples. Also the
acetylated forms 3- and 15-acetyldeoxynivalenol (3 and 15ADON) were present in half of the
samples, however, at lower concentrations (86 3 mg 3ADON and 106 7 mg 15ADON/kg). Only
in 17.5% of the farms, DON was detected in serum samples at a mean serum concentration and
standard deviation (SD) of 116 19 ng/mL. The maximum serum concentration of 49 ng DON/
mL was detected in broilers which were fed a diet that was contaminated with 191 mg DON/kg,
whereas the maximum concentration of DON in feed was 751 mg/kg. Besides, 3 and 15ADON
were only detected in 10% of the serum samples (max. 1.3 ng/mL). Sulfate conjugates of DON
were only detected in a few serum samples. Qualitative screening for phase II metabolites of other
mycotoxins showed similar results. Overall, correlations between feed and serum concentrations
of all mycotoxins were lacking (R2 = 0.18 for DON).Key words: biomonitoring, mycotoxins, feed, serum, broiler chickens
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Mycotoxins are secondary metabolites pro-
duced by different fungal species and are
frequently found in food and feed. More than
400 different mycotoxins have been identified,
with the most prevalent being aflatoxins (e.g.,
aflatoxin B1; AFB1), fumonisins (FB), zear-
alenone (ZEN), type B trichothecenes (e.g.,
deoxynivalenol; DON), type A trichothecenes
(e.g., T-2 toxin; T-2), and ochratoxin A (OTA).
These toxins are known to exert toxic effects in
livestock, causing vague clinical symptoms
such as disruption of growth and production
parameters and suppression of the immunity
(Bryden, 2012). Hence, maximum concentra-
tions for AFB1, maximum guidance values for
DON, ZEN, OTA, and FB and indicative values
for T-2 in animal feed have been established in
the European Union. Mycotoxin exposure can
have a major negative impact on the poultry
industry, as even low to moderate contamination
levels affect organs in poultry such as the
gastrointestinal tract and the liver as well as the
immune system. This can result in an array of
metabolic, physiological, and immunological
disturbances and a reduced productivity of the
birds (Bryden, 2012).
Being of major agroeconomic importance,
assessment of mycotoxin exposure is crucial.
Until now, mycotoxin exposure in animals is
mainly monitored through feed analysis. How-
ever, feed analysis may disregard the so-called
hotspots, which are local areas of higher
contamination levels within the feed, and there-
fore complicate representative sample collection
(Bryden, 2012). Hence, proper sampling is
important to ensure more reliable results. An
alternative to perform mycotoxin exposure
assessment has been proposed, namely the direct
measurement of biomarkers of exposure in bio-
logical matrices, such as blood, urine, or feces
(Lauwers et al., 2019). Nevertheless, similar to
feed analysis, biomonitoring through measure-
ment of biomarkers in biological matrices comes
along with certain disadvantages, for example,
accomplishing an adequate time point of sample
taking in relation to the oral ingestion of myco-
toxins. Biomarkers for mycotoxin exposure in
biological matrices can either be the mycotoxin
itself or its phase I and II metabolites (Lauwerset al., 2019). Biotransformation into phase I and
II metabolites is specific for each mycotoxin and
toxicokinetic pathways of mycotoxins also differ
between animal species (Broekaert et al., 2015).
In pigs, for example, glucuronidation to DON-3-
glucuronide is a major phase II metabolization
pathway, while in broiler chickens sulfation to
DON-3ɑ-sulfate (DON3S) is the most important
step during metabolization (Devreese et al.,
2015).
Masked or modified mycotoxins in feed, as
metabolites of fungi or plants, have been
described and investigated as well, but legal
regulations are mostly lacking. For example, the
conjugated glucoside metabolite of DON (DON-
3-glucoside) is fully hydrolyzed to DON in pigs,
but no hydrolyzation to DON is seen in broiler
chickens (Broekaert et al., 2017). Likewise, 3 and
15ADON are completely hydrolyzed to DON in
pigs after oral absorption, whereas in broiler
chickens, only 3ADON is completely hydrolyzed
to DON but 15ADON is partially hydrolyzed.
Hence, 15ADON is stated to be as toxic as or even
more toxic than DON (Broekaert et al., 2015).
Because modified mycotoxins can be toxic
themselves and can be hydrolyzed either partially
or completely in vivo to form their parent
mycotoxin, increasing the exposure of these
parent mycotoxins to the animal, novel bio-
monitoring methodologies should also take into
account the modified mycotoxins.
Hitherto, studies on correlations between
mycotoxin concentrations found in biological
matrices compared with concentrations found in
feed mostly investigated correlations for DON
and/or ZEN in pigs, especially in urine. Only a
few of these studies have been performed in
broiler chickens. Therefore, the aim of this
study was to comparatively evaluate mycotoxin
exposure in broiler chickens under field condi-
tions by feed analysis and by analysis of my-
cotoxins and their in vivo phase I and II
metabolites in serum.
MATERIALS AND METHODS
Feed and Serum Sample Collection
Forty randomly selected Ross 308 broiler
farms, located in Flanders (Belgium), were
included in this study. Samples were collected
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each farm, 10 nonclinically diseased broilers
were randomly selected from evenly distributed
positions along the house without considering
gender. The birds were euthanized by cervical
dislocation by an experienced veterinarian.
Immediately after euthanasia, blood was with-
drawn by section of the jugular vein and
collected into serum tubes, which were stored
at # 215C until analysis. All chickens
involved in this study were fed ad libitum.
Blood sampling was executed at approximately
the same time point (noon) on each farm on
different days. In addition, a feed subsample of
each 0.5 kg was collected on each farm at both
the beginning and the end of the feed line and
stored at # 215C until analysis. All farmers
claimed that no mycotoxin binder was added to
the feed; however, this could not be confirmed
at the level of the feed mills. For each farm the
subsamples were ground and subsequently
pooled to one final sample prior analysis (1/1,
m/m).
Serum Analysis
Serum samples were quantitatively analyzed
for 24 mycotoxins and major in vivo phase I
metabolites, namely DON, de-epoxy-
deoxynivalenol 1 (DOM1), the sum of 3 and
15ADON, T-2, HT-2 toxin (HT-2), aflatoxin B1
(AFB1), aflatoxin M1 (AFM1), OTA, enniatin
A, enniatin B, enniatin A1, enniatin B1, beau-
vericin (BEA), a-zearalenol (AZEL), a-zear-
alanol (AZAL), ZEN, b-zearalenol (BZEL),
b-zearalanol (BZAL), tenuazonic acid, alter-
nariol (AOH), alternariol mono-methyl-ether
(AME), fumonisin B1 (FB1), and fumonisin
B2 (FB2) using an in-house validated multi-
mycotoxin liquid chromatography tandem mass
spectrometry (LC-MS/MS) method, as
described by Lauwers et al. (2019). A qualita-
tive approach to detect phase II metabolites was
performed using a validated ultraperformance
liquid chromatography—high resolution mass
spectrometry (UPLC-HRMS) method, as
described by Lauwers et al. (2019) as well.
Feed Analysis
All 40 feed samples were quantitatively
analyzed using a validated multimycotoxinLC-MS/MS as described by Monbaliu et al.
(2010) for the simultaneous detection of 23
mycotoxins: AFB1, aflatoxin B2 (AFB2), afla-
toxin G1 (AFG1), aflatoxin G2 (AFG2), OTA,
ZEN, FB1, FB2, fumonisin B3, T2, HT-2,
nivalenol, 3ADON, 15ADON, diacetoxy-
scirpenol (DAS), fusarenon-X (FusX), neo-
solaniol (NEO), altenuene (ALT), AOH, AME,
roquefortine-C (ROQ-C), sterigmatocystin, and
enniatins (ENN) in feed.
Statistical Analysis
To reveal possible correlations between
mycotoxin concentrations detected in feed and
those detected in serum, a coefficient of deter-
mination (R2) was calculated for each myco-
toxin using Microsoft Excel.RESULTS AND DISCUSSION
The mycotoxin concentrations detected in
both feed and serum samples are shown in
Table 1. No AFB1, HT-2, BEA, AZEL, AZAL,
BZEL, BZAL, or AOH were detected in serum
and no AFB1, AFB2, AFG1, AFG2, HT2,
DAS, FusX, NEO, ALT, AOH, or ROQ-C were
detected in feed samples. None of the myco-
toxin concentrations detected in feed exceeded
the European maximum (guidance) levels or
indicative values. The most noticeable were the
mean mycotoxin concentrations detected in
serum being only a very small fraction of those
detected in feed. Especially in chickens the oral
bioavailability of most mycotoxins is low when
compared with other animals. For example,
DON was completely absorbed after oral
administration to pigs, whereas only 10%
(Broekaert et al., 2015) and 19.3% (Osselaere
et al., 2013) of the mycotoxin was reported to
be absorbed in the digestive tract of broiler
chickens.
In this study, DON was the most frequently
occurring mycotoxin, contaminating 75% of
feed samples with a mean (6SD) and maximum
mycotoxin concentration of 270 6 171 mg/kg
and 751 mg/kg feed, respectively. Similarly, in a
global survey DON was prevalent in 37,940 of
59,107 animal feed samples collected between
2008 and 2017, which was 64% of positive
samples and thus being the most frequently
Table 1. Observed mycotoxin concentrations in feed (n = 40 farms) and serum (n = 40, result per farm is the



















NIV 5.0 32 6 8 38 26 NA NA NA NA
DON 75.0 270 6 171 751 61 17.5 11.7 6 19.1 48.8 1.6
3ADON 49.0 8 6 39 14 5 10.01 1.2 6 0.11 1.31 1.21
15ADON 51.0 10 6 7 27 3 10.01 1.2 6 0.11 1.31 1.21
FB1 40.0 147 6 143 550 42 12.5 1.9 6 1.1 3.7 1.1
FB2 20.0 83 6 31 133 38 2.5 1.72 1.7 1.7
FB3 10.0 56 6 12 70 47 NA NA NA NA
ZEN ND ND ND ND 5 3.1 6 2.4 4.8 1.4
ENN 22.5 166 6 221 640 14 ND ND ND ND
T-2 5.0 11 6 2 13 10 ND ND ND ND
AME 2.5 312 31 31 2.5 4.32 4.3 4.3
ST 5.0 13 6 1 13 13 ND ND ND ND
OTA ND ND ND ND 5.0 2.0 6 1.2 2.8 1.1
TEA NA NA NA NA 22.5 5.0 6 2.9 10.1 1.8
Data are presented as percentages of positive samples, mean concentrations with standard deviations (SD) and maximum
concentrations.
Abbreviations: 3ADON, 3-acetyldeoxynivaleol; 15ADON, 15-acetyldeoxynivaleol; AME, alternariol-monomethyl-ether;
DON, deoxynivalenol; ENN, enniatins; FB1, fumonisin B1; FB2, fumonisin B2; FB3, fumonisin B3; NA, not analyzed;
ND in feed, not detected or below decision limit (CCɑ); ND in serum, not detected or below limit of detection (LOD);
NIV, nivalenol; OTA, ochratoxin A; ST, sterigmatocystine; T-2, T-2 toxin; TEA, tenuazonic acid; ZEN, zearalenone.
1Presented as sum of 3 and 15ADON.
2Only one positive sample.
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Dorninger et al., 2019). Remarkably, in this
study, DON was only detected in serum samples
of one of eight DON positive farms based on
feed analysis. Accordingly, DON undergoes
extensive biotransformation in broiler chicken
and is eliminated rapidly (Devreese et al., 2015).
The DON positive serum samples were char-
acterized by an average serum concentration
(6SD) of 11.7 6 19.1 ng/mL. The highest
serum concentration of 48.8 ng/mL was
observed in chickens fed a diet containing
191 mg DON/kg feed, whereas the highest
observed concentration of DON in feed in this
study was 751 mg/kg feed, detected at another
farm. Besides DON, the acetylated forms 3 and
15ADON were detected in feed samples of 50%
of the farms, but at a lower mean (6SD) and
maximum concentration of 8 6 3 mg 3ADON
and 106 7 mg 15ADON/kg, and 14 mg 3ADON
and 27 mg 15ADON/kg, respectively. By
contrast, 3 and/or 15ADON were only detect-
able in 10% of the serum samples tested, at
mean (6SD) and maximum concentrations of
1.2 6 0.1 ng/mL and 1.3 ng/mL, respectively.Accordingly, after oral administration, a com-
plete presystemic hydrolysis of 3ADON to
DON and 75% hydrolysis of 15ADON to DON
was observed in broiler chickens (Broekaert
et al., 2015).
In contrast to the type B trichothecene DON,
type A trichothecene T-2 was only present in the
feed at 2 of 40 farms at mean and maximum
concentrations of 11 6 2 and 13 mg/kg feed.
This 5% prevalence is in contrast to the results
of the mycotoxin survey from Gruber-
Dorninger et al. (2019), where 31% of the
21,036 feed samples taken in Central Europe
were contaminated by T-2, although the mean
concentration of 11 mg/kg was similar to this
study. No T-2 has been detected in serum sam-
ples during screening. In accordance, after oral
administration of T-2 to broiler chickens at a
dose of 0.02 mg/kg BW no plasma levels of T-2
or HT-2 were detected (Osselaere et al., 2013)
and a fast elimination was seen via excreta after
administration of T-2 to broiler chickens.
During the metabolization of DON, de-
epoxidation of the active epoxide group to
DOM1 by the gut microbiota was observed as a
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DOM1 was detected in broiler chickens after
single bolus administration (Osselaere et al.,
2013). In this study, DOM1 was detected in
broiler chicken serum on 10% of the farms at
mean (6SD) and maximum concentrations of
1.5 6 0.2 ng/mL and 1.7 ng/mL, respectively.
Sulfation has been discovered as a major
metabolization pathway in chickens, with
DON3S being the most dominant metabolic
product of DON in chickens (Devreese et al.,
2015). However, in this study, DON-15-sulfate
(DON15S) was detected in only 1 of 400 serum
samples, and noDON3Swas observed.Although
another biotransformation pathway of DON is
glucuronidation, especially in mammals, only
traces of DON-3a-glucuronide were detected
after oral and intravenous administration of DON
to broilers (Devreese et al., 2015). In accordance,
no DON-glucuronide metabolites were detected
in this study. Qualitative screening for phase II
metabolites of other mycotoxins in this study
revealed only very few positive samples, as well.
During quantitative screening, phase I metabolite
AFM1, a common metabolite of AFB1, was not
detected in serum samples. Alpha-zearalanol was
detected in serum samples of 4 of 40 farms at
mean (6SD) and maximum concentrations of
2.9 6 2.1 ng/mL and 5.9 ng/mL, respectively.
Beta-zearalanol was present in serum samples of
2 of 40 farms at a mean (6SD) concentration of
8.3 6 8.7 ng/mL and a maximum concentration
of 14.5 ng/mL. No AZEL and BZEL were
detected after chronic exposure to low doses of
ZEN in this study. In accordance with literature,
however, after single bolus of ZEN, AZEL and
BZEL are the main metabolites of ZEN in most
avian species (Osselaere et al., 2013).
Zearalenone was observed in serum samples
of 5% of the farms at a maximum concentration
of 4.8 ng/mL and a mean (6SD) concentration
of 3.2 6 2.4 ng/mL. Remarkably, no ZEN was
detected in the matching feed samples. In
addition, OTA was present in 5% of the serum
samples but could not be detected in feed. Both
could be associated with the sensitivity of the
detection method, and differences in the limit of
detection and decision limit in serum compared
with feed (Monbaliu et al., 2010; Lauwers et al.,
2019). Besides, OTA shows a long elimination
half-life of almost 24 h, as well as an especiallyhigh plasma protein binding in broiler chickens,
which prolongs the presence of OTA in the
body. In addition, enterohepatic circulation has
been suggested as a disposition process of OTA
in broiler chickens (Devreese et al., 2018).
These toxicokinetic parameters imply that
broiler chickens tested in this study could have
been exposed to OTA earlier in their lives.
In accordance with the high prevalence of the
emerging Fusarium and Alternaria mycotoxins
published in literature (Streit et al., 2013), ENN
have been detected in 22.5% of the feed sam-
ples, while no traces have been detected in
serum. In addition, AME could not be detected
in serum samples but was present in feed sam-
ples of 1 of 40 farms. Tenuazonic acid could not
be analyzed in feed but was observed in serum
samples of 9 out of 40 farms and showed mean
(6SD) and maximum concentrations of
5.0 6 2.9 and 10.1 ng/mL, respectively. In a
study of Streit et al. (2013), ENN, AME, and
TEA contaminated 96, 82, and 6% of the 83
feed samples, respectively. The toxicity and
toxicokinetic pathways of emerging mycotoxins
are not yet fully investigated and no legislative
regulation has been set up. Therefore, further
research on in vivo toxicity and toxicokinetics
of these emerging mycotoxins is needed in order
to establish legal maximum or guidance levels.
Figure 1 shows a lack of correlation between
concentrations of DON and its metabolites in feed
and in serum samples in this study (R2 = 0.1768).
Correlations could not be calculated for other
mycotoxins because no other mycotoxin was
detected simultaneously in feedand serumonmore
than 2 farms. Exposure assessment studies often
aim to find correlations betweenmycotoxins found
in feed or biologicalmatrices and impact on animal
health. To the authors’ knowledge, statistically
significant correlations between clinical symptoms
in broiler chickens and their exposure to myco-
toxins, assessed by measurement of biomarkers of
exposure, were not demonstrated yet. Neverthe-
less, some studies managed to demonstrate the
involvement of mycotoxins by assessing
biomarkers of exposure in certain diseases in pigs.
In a study of Van Limbergen et al. (2017) e.g., a
positive correlation (R = 0.52) between the con-
centration of DON in feed and in plasma between
herds with and without tail necrosis in sows could




































feed concentration DON + 3ADON + 15 ADON (μg/kg)
Figure 1. Serum concentrations of DON, 3ADON, 15ADON, and DOM1 in ng/mL in comparison with feed con-
centrations of DON, 3ADON, and 15ADON in mg/kg. R2: coefficient of determination. Abbreviations: DON, deoxy-
nivalenol; 3ADON, 3-acetyldeoxynivaleol; 15ADON, 15-acetyldeoxynivaleol; DOM1, de-epoxy-deoxynivalenol 1.
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an estimation of the effect of mycotoxin exposure
on animal health. Biomarkers of effect link
biochemical, physiological, or behavioral alter-
ations in the organism to possible adverse health
effects. For mycotoxins, however, the only known
biomarker of effect so far is the increase of the
sphinganine/sphingosine ratio in blood, plasma, or
tissue, which is seen after disruption of the sphin-
golipids biosynthesis caused by fumonisins
(Bryden, 2012).
This study reveals how biomonitoring of
mycotoxins based on determining their con-
centration and concentrations of related phase I
and II metabolites in blood serum as biomarker
of exposure can give an underestimation of the
actual mycotoxin exposure in broiler chickens,
probably due to the limited oral absorption and
fast and efficient elimination of many myco-
toxins in poultry species. However, even though
the concentrations of mycotoxins detected in
serum compared with those detected in feed
showed a lack of correlation, serum analysis
may show actual exposure to mycotoxins. Up to
today mycotoxin exposure monitored by the
means of feed analysis remains most suited.
Further research on biomarkers of exposure,especially on biomarkers of effect, to assess
mycotoxin exposure is needed to concur with
the benefits of feed analysis on mycotoxins.
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